Skip to main content
LG Corp. logo

LG Corp. — Investor Relations & Filings

Ticker · 003550 ISIN · KR7003550001 KO Manufacturing
Open in API
Filings indexed 624 across all filing types
Latest filing 2022-09-28 Report Publication Anno…
Country KR South Korea
Listing KO 003550

About LG Corp.

https://www.lgcorp.com

LG Corp. is a multinational holding company that manages a diverse portfolio of subsidiary companies operating globally. The corporation's primary business areas are electronics, chemicals, and telecommunications. Key affiliates include LG Electronics, a leading manufacturer of consumer electronics and home appliances; LG Chem, a provider of advanced materials, petrochemicals, and life science products; and LG Energy Solution, a major developer of lithium-ion batteries for electric vehicles and energy storage systems. Other significant subsidiaries operate in sectors such as displays (LG Display), electronic components (LG Innotek), telecommunications services (LG U+), and IT solutions (LG CNS).

Recent filings

Filing Released Lang Actions
지속가능경영보고서등관련사항(자율공시)
Report Publication Announcement Classification · 100% confidence The document is a short regulatory filing (1,766 characters) that serves as a formal announcement of the publication of the 'LG ESG Reporting 2021-2022'. It explicitly states in section 7 that the detailed report is attached as a separate document. According to the 'Menu vs Meal' rule, an announcement of a report's publication is classified as a Report Publication Announcement (RPA).
2022-09-28 Korean
투자판단관련주요경영사항(자회사의 주요경영사항)(Tigulixostat(통풍치료제) 미국 임상 3상 시험계획 승인)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from LG regarding a material business event, specifically the approval of a Phase 3 clinical trial for a gout treatment (Tigulixostat) by the US FDA. This type of disclosure regarding clinical trial progress and regulatory approval is a standard corporate announcement of material information. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-09-28 Korean
투자판단관련주요경영사항(자회사의 주요경영사항)(Tigulixostat(통풍치료제) 유럽 임상 3상 시험계획 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from LG regarding a material business event, specifically the application for a Phase 3 clinical trial for a gout treatment (Tigulixostat) in Europe. It follows the standard format for a 'Major Management Matter' (주요경영사항) disclosure, which is a common regulatory filing type in the Korean market. Since it does not fit into specific categories like M&A, dividends, or financial reports, and is a formal regulatory disclosure of a material event, it is classified as a Regulatory Filing (RNS).
2022-09-16 Korean
투자판단관련주요경영사항(자회사의 주요경영사항)(Tigulixostat(통풍치료제) 중국 임상 3상 시험계획 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from LG regarding a material business event, specifically the application for a Phase 3 clinical trial for a gout treatment (Tigulixostat) in China. It follows the standard format for 'Major Management Matters' (주요경영사항) filings in the Korean market. Since it details a specific regulatory event (clinical trial application) and does not fit into categories like financial reports, dividends, or shareholder meetings, it is classified as a general regulatory filing.
2022-09-05 Korean
투자판단관련주요경영사항(자회사의 주요경영사항)(Tigulixostat(통풍치료제) 미국 임상 3상 시험계획 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from LG regarding a material business event, specifically the submission of a Phase 3 clinical trial application for a gout treatment (Tigulixostat) to the US FDA. It follows the standard format for 'Major Management Matters' (주요경영사항) filings in the Korean market. Since it details a specific regulatory/clinical development event rather than a financial report, dividend, or governance change, it falls under the general regulatory filing category.
2022-09-01 Korean
대규모기업집단현황공시[분기별공시(대표회사용)]
Major Shareholding Notification Classification · 100% confidence The document is a 'Large Business Group Status Disclosure' (기업집단현황공시) filed by LG Corporation. It contains detailed tables regarding share ownership among domestic affiliates as of June 30, 2022. This type of regulatory filing in South Korea is a mandatory disclosure of corporate group structure and shareholding, which falls under the 'Regulatory Filings' category as it is a specific statutory disclosure requirement that does not fit into standard financial reporting categories like 10-K or IR.
2022-08-31 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.